G9830 Her-2 pos
G-Codes
Also known as: HER2 positive, HER-2 positive breast cancer
Healthcare quality measure documenting Human Epidermal Growth Factor Receptor 2 positive breast cancer status.
Clinical Context
Quality measure used in breast cancer oncology to identify patients with HER2-positive tumors, which have prognostic and therapeutic implications, particularly for trastuzumab (Herceptin) eligibility.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.